Progress in the Early Detection of Risk of End-Stage Kidney Disease in Diabetes at Last?
- PMID: 36762398
- PMCID: PMC12376300
- DOI: 10.1093/clinchem/hvac215
Progress in the Early Detection of Risk of End-Stage Kidney Disease in Diabetes at Last?
Keywords: chronic kidney disease; diabetes; diabetic kidney disease; kidney.
Conflict of interest statement
Comment on
-
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.Sci Transl Med. 2022 Aug 10;14(657):eabj2109. doi: 10.1126/scitranslmed.abj2109. Epub 2022 Aug 10. Sci Transl Med. 2022. PMID: 35947673 Free PMC article.
References
-
- Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M . Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158:825–30. - PubMed
-
- Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol 2020;16:51–64. - PubMed
-
- Miller WG, Kaufman HW, Levey AS, Straseski JA, Wilhelms KW, Yu HE, et al. National kidney foundation laboratory engagement working group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories. Clin Chem 2022;68:511–20. - PubMed
-
- Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol 2016;12:325–38. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
